Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Opioid prescribing for cancer patients reporting no pain declined substantially across a single Connecticut health system from 2016 to 2020, while prescribing for patients reporting pain remained stable.
Oncology, Medical May 26th 2026
Pharmacy Times
Comprehensive data package, including structural and functional analytical data, clinical pharmacokinetic data, and a comparative clinical study demonstrating that Bildyos and Bilprevda are highly similar to and have no clinically meaningful differences from their reference products.
Clinical Pharmacology September 3rd 2025
Clinical Oncology News
Novel BRAF inhibitor gel reactivates disrupted MAPK signaling pathways in affected skin areas, restoring normal function while maintaining systemic anticancer therapy effectiveness.
Dermatology June 24th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS